{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T10:47:18Z","timestamp":1790765238026,"version":"4.1.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,10,10]]},"DOI":"10.7759\/cureus.10890","type":"journal-article","created":{"date-parts":[[2020,10,11]],"date-time":"2020-10-11T01:34:27Z","timestamp":1602380067000},"source":"Crossref","is-referenced-by-count":8,"title":["Reversible Myelosuppresion With Prolonged Usage of Linezolid in Treatment of Methicillin-Resistant Staphylococcus aureus"],"prefix":"10.7759","author":[{"given":"Sanjana","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arshi","family":"Syal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Tahlan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baldeep","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.2174\/1389200216666151001121004","article-title":"Linezolid induced adverse drug reactions - an update","volume":"16","author":"Kishor K","year":"2015","unstructured":"Kishor K, Dhasmana N, Kamble SS, Sahu RK. Linezolid induced adverse drug reactions - an update. Curr Drug Metab. 2015, 16:553-559. 10.2174\/1389200216666151001121004","journal-title":"Curr Drug Metab"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo CA","year":"1981","unstructured":"Naranjo CA, Busto U, Sellers EM, et al.. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981, 30:239-245. 10.1038\/clpt.1981.154","journal-title":"Clin Pharmacol Ther"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(06)70588-6","article-title":"MRSA becomes growing problem in US emergency departments","volume":"6","author":"Ahmad K","year":"2006","unstructured":"Ahmad K. MRSA becomes growing problem in US emergency departments. Lancet Infect Dis. 2006, 6:621. 10.1016\/S1473-3099(06)70588-6","journal-title":"Lancet Infect Dis"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.2147\/CEOR.S46991","article-title":"Economic burden of inpatient and outpatient antibiotic treatment for methicillin-resistant Staphylococcus aureus complicated skin and soft-tissue infections: a comparison of linezolid, vancomycin, and daptomycin","volume":"5","author":"Stephens JM","year":"2013","unstructured":"Stephens JM, Gao X, Patel DA, Verheggen BG, Shelbaya A, Haider S. Economic burden of inpatient and outpatient antibiotic treatment for methicillin-resistant Staphylococcus aureus complicated skin and soft-tissue infections: a comparison of linezolid, vancomycin, and daptomycin . Clinicoecon Outcomes Res. 2013, 5:447-57. 10.2147\/CEOR.S46991","journal-title":"Clinicoecon Outcomes Res"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s11096-014-9961-6","article-title":"Retrospective analysis of the risk factors for linezolid-induced thrombocytopenia in adult Japanese patients","volume":"36","author":"Hirano R","year":"2014","unstructured":"Hirano R, Sakamoto Y, Tachibana N, Ohnishi M. Retrospective analysis of the risk factors for linezolid-induced thrombocytopenia in adult Japanese patients. Int J Clin Pharm. 2014, 36:795-799. 10.1007\/s11096-014-9961-6","journal-title":"Int J Clin Pharm"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s10156-010-0188-8","article-title":"Chronic liver disease increases the risk of linezolid-related thrombocytopenia in methicillin-resistant Staphylococcus aureus-infected patients after digestive surgery","volume":"17","author":"Ikuta S","year":"2011","unstructured":"Ikuta S, Tanimura K, Yasui C, et al.. Chronic liver disease increases the risk of linezolid-related thrombocytopenia in methicillin-resistant Staphylococcus aureus-infected patients after digestive surgery. J Infect Chemother. 2011, 17:388-391. 10.1007\/s10156-010-0188-8","journal-title":"J Infect Chemother"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdg211","article-title":"Safety, efficacy and pharmacokinetics of linezolid for treatment of resistant Gram-positive infections in cancer patients with neutropenia","volume":"14","author":"Smith PF","year":"2003","unstructured":"Smith PF, Birmingham MC, Noskin GA, Meagher AK, Forrest A, Rayner CR, Schentag JJ. Safety, efficacy and pharmacokinetics of linezolid for treatment of resistant Gram-positive infections in cancer patients with neutropenia. Ann Oncol. 2003, 14:795-801. 10.1093\/annonc\/mdg211","journal-title":"Ann Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1128\/aac.46.8.2723-2726.2002","article-title":"Hematologic effects of linezolid: summary of clinical experience","volume":"46","author":"Gerson SL","year":"2002","unstructured":"Gerson SL, Kaplan SL, Bruss JB, Le V, Arellano FM, Hafkin B, Kuter DJ. Hematologic effects of linezolid: summary of clinical experience. Antimicrob Agents Chemother. 2002, 46:2723-6. 10.1128\/aac.46.8.2723-2726.2002","journal-title":"Antimicrob Agents Chemother"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1592\/phco.21.11.1010.34517","article-title":"Hematologic effects of antimicrobials: focus on the oxazolidinone linezolid","volume":"21","author":"Kuter DJ","year":"2001","unstructured":"Kuter DJ, Tillotson GS. Hematologic effects of antimicrobials: focus on the oxazolidinone linezolid. Pharmacotherapy. 2001, 21:1010-1013. 10.1592\/phco.21.11.1010.34517","journal-title":"Pharmacotherapy"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-003-0681-6","article-title":"Challenges with linezolid therapy and reversible pancytopenia","volume":"82","author":"Nimeiri HS","year":"2003","unstructured":"Nimeiri HS, Nemiary DS. Challenges with linezolid therapy and reversible pancytopenia. Ann Hematol. 2003, 82:533. 10.1007\/s00277-003-0681-6","journal-title":"Ann Hematol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1086\/341309","article-title":"Linezolid-induced pancytopenia","volume":"35","author":"Halpern M","year":"2002","unstructured":"Halpern M. Linezolid-induced pancytopenia. Clin Infect Dis. 2002, 35:347-348. 10.1086\/341309","journal-title":"Clin Infect Dis"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1155\/2005\/961613","article-title":"Probable linezolid-induced pancytopenia","volume":"16","author":"Lakhani N","year":"2005","unstructured":"Lakhani N, Thompson W, Bombassaro AM. Probable linezolid-induced pancytopenia. Can J Infect Dis Med Microbiol. 2005, 16:286-288. 10.1155\/2005\/961613","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dks153","article-title":"Therapeutic drug monitoring may improve safety outcomes of long-term treatment with linezolid in adult patients","volume":"67","author":"Pea F","year":"2012","unstructured":"Pea F, Viale P, Cojutti P, Del Pin B, Zamparini E, Furlanut M. Therapeutic drug monitoring may improve safety outcomes of long-term treatment with linezolid in adult patients. J Antimicrob Chemother. 2012, 67:2034-2042. 10.1093\/jac\/dks153","journal-title":"J Antimicrob Chemother"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2007.04.005","article-title":"The site of action of oxazolidinone antibiotics in living bacteria and in human mitochondria","volume":"26","author":"Leach KL","year":"2007","unstructured":"Leach KL, Swaney SM, Colca JR, et al.. The site of action of oxazolidinone antibiotics in living bacteria and in human mitochondria. Mol Cell. 2007, 26:393-402. 10.1016\/j.molcel.2007.04.005","journal-title":"Mol Cell"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1C361","article-title":"Mechanisms for linezolid-induced anemia and thrombocytopenia","volume":"37","author":"Bernstein WB","year":"2003","unstructured":"Bernstein WB, Trotta RF, Rector JT, Tjaden JA, Barile AJ. Mechanisms for linezolid-induced anemia and thrombocytopenia. Ann Pharmacother. 2003, 37:517-520. 10.1345\/aph.1C361","journal-title":"Ann Pharmacother"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-013-2041-3","article-title":"Therapeutic drug monitoring and receiver operating characteristic curve prediction may reduce the development of linezolid-associated thrombocytopenia in critically ill patients","volume":"33","author":"Dong HY","year":"2014","unstructured":"Dong HY, Xie J, Chen LH, Wang TT, Zhao YR, Dong YL. Therapeutic drug monitoring and receiver operating characteristic curve prediction may reduce the development of linezolid-associated thrombocytopenia in critically ill patients. Eur J Clin Microbiol Infect Dis. 2014, 33:1029-1035. 10.1007\/s10096-013-2041-3","journal-title":"Eur J Clin Microbiol Infect Dis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/42691-reversible-myelosuppresion-with-prolonged-usage-of-linezolid-in-treatment-of-methicillin-resistant-staphylococcus-aureus","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:18:41Z","timestamp":1707506321000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/42691-reversible-myelosuppresion-with-prolonged-usage-of-linezolid-in-treatment-of-methicillin-resistant-staphylococcus-aureus"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,10]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.10890","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10,10]]}}}